PMID- 26197729
OWN - NLM
STAT- MEDLINE
DCOM- 20171221
LR  - 20181202
IS  - 1520-6777 (Electronic)
IS  - 0733-2467 (Linking)
VI  - 35
IP  - 7
DP  - 2016 Sep
TI  - Quality of life after suprapubic catheter placement in patients with neurogenic 
      bladder conditions.
PG  - 831-5
LID - 10.1002/nau.22812 [doi]
AB  - AIMS: To evaluate quality of life in patients with neurogenic bladder (NGB) 
      conditions who have elected to undergo suprapubic catheterization (SPC), as well 
      as assess adverse events (AEs) related to the procedure. METHODS: This is a 
      retrospective review from a database of NGB patients from 1/1/2003 to 6/30/2013. 
      Patients who underwent SPC placement were invited to complete a validated, single 
      item Patient Global Impression of Improvement (PGI-I) questionnaire. Success or 
      positive response was defined as 1 or 2 on a scale of 1-7. All patients were 
      included in the assessment of AEs. RESULTS: Of the 128 patients who underwent 
      SPC, 89 patients (54 female, 35 male) met inclusion criteria. Response rate to 
      the PGI-I questionnaire was 65.2% (58/89). Mean age at the time of SPC placement 
      was 54.4 years (+/- 14.4). The mean time from SPC placement to PGI-I questionnaire 
      was 48.3 months (Range 4.4-128.4). Overall, success was seen in 49/58 patients 
      (84.5%). Only 5.2% (3/58) patients reported a negative PGI-I (score 5/7). There 
      was an 18.8% rate of short term complications, with the majority of these being 
      classified as Clavien I. There was one Clavien IIIb complication (0.8%), which 
      consisted of a small bowel perforation. CONCLUSIONS: SPC is an effective bladder 
      management in carefully selected NGB patients who have failed other options. Over 
      80% considered the SPC to have improved their urological quality of life with a 
      mean time to questionnaire of 4 years. Severe AEs are rare, though can be 
      particularly serious in this group of neurologically impaired patients. 
      Neurourol. Urodynam. 35:831-835, 2016. (c) 2015 Wiley Periodicals, Inc.
CI  - (c) 2015 Wiley Periodicals, Inc.
FAU - Lavelle, Rebecca S
AU  - Lavelle RS
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
FAU - Coskun, Burhan
AU  - Coskun B
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
FAU - Bacsu, Chasta D
AU  - Bacsu CD
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
FAU - Gliga, Louise A
AU  - Gliga LA
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
FAU - Christie, Alana L
AU  - Christie AL
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
FAU - Lemack, Gary E
AU  - Lemack GE
AD  - University of Texas Southwestern Medical Center, Dallas, Texas.
LA  - eng
PT  - Journal Article
DEP - 20150721
PL  - United States
TA  - Neurourol Urodyn
JT  - Neurourology and urodynamics
JID - 8303326
SB  - IM
CIN - J Urol. 2018 Jan;199(1):34. PMID: 29310196
MH  - Adult
MH  - Aged
MH  - Catheterization/*adverse effects
MH  - Catheters, Indwelling/*adverse effects
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Quality of Life/*psychology
MH  - Retrospective Studies
MH  - Surveys and Questionnaires
MH  - Treatment Outcome
MH  - Urinary Bladder, Neurogenic/*psychology/*surgery
OTO - NOTNLM
OT  - complications
OT  - neurogenic bladder conditions
OT  - quality of life
OT  - suprapubic catheter
EDAT- 2015/07/23 06:00
MHDA- 2017/12/22 06:00
CRDT- 2015/07/23 06:00
PHST- 2015/02/18 00:00 [received]
PHST- 2015/05/27 00:00 [accepted]
PHST- 2015/07/23 06:00 [entrez]
PHST- 2015/07/23 06:00 [pubmed]
PHST- 2017/12/22 06:00 [medline]
AID - 10.1002/nau.22812 [doi]
PST - ppublish
SO  - Neurourol Urodyn. 2016 Sep;35(7):831-5. doi: 10.1002/nau.22812. Epub 2015 Jul 21.